Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2003
05/01/2003US20030082225 Sterile, breathable patch for treating wound pain
05/01/2003US20030082224 Antitumor, anticancer agents
05/01/2003US20030082223 Mixture contains flow control agent and thickener
05/01/2003US20030082219 Applying active materials to an absorber; cosmetics
05/01/2003US20030082216 Needle-less parenteral introduction device
05/01/2003US20030082215 Fenofibrate galenic formulations and method for obtaining same
05/01/2003US20030082214 Oil in water emulsion containing antidepressant, anesthetics
05/01/2003US20030082213 Use of microparticles combined with submicron oil-in-water emulsions
05/01/2003US20030082206 Method of preserving infectious recombinant viruses, aqueous viral suspension, and use as medicament
05/01/2003US20030082198 Administering complex of heat shock protein and antigen
05/01/2003US20030082197 Administering complex of heat shock protein and antigen
05/01/2003US20030082193 Immunoassay using computer; forming vaccine, immunoglobulins
05/01/2003US20030082161 Efficient gene therapy; sustained release
05/01/2003US20030082154 Fusogenic lipids and vesicles
05/01/2003US20030082137 Interleukin-3 gene therapy for cancer
05/01/2003US20030082128 Homogeneous mixtures of silicone oils and organic oils
05/01/2003US20030082109 Chewable or edible substitutes for smoking for enabling gradual withdrawl from dependency or addiction
05/01/2003US20030082107 Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
05/01/2003US20030082105 Selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions
05/01/2003US20030080085 Coated microfluidic delivery system
05/01/2003US20030079747 Method of decreasing fasting sugars and weight gains in diabetic patients
05/01/2003CA2764642A1 Taste masking spill-resistant formulation
05/01/2003CA2739611A1 Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
05/01/2003CA2469474A1 Potentiated topical compositions
05/01/2003CA2464561A1 Methods of treatment using a gastric retained losartan dosage
05/01/2003CA2464284A1 Magnetic nanodispersion comprising cyclodextrines and method for the production thereof
05/01/2003CA2464261A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction
05/01/2003CA2463951A1 Solid pharmaceutical formulation for a piperazine urea derivative
05/01/2003CA2463803A1 Biphasic mixtures of glp-1 and insulin
05/01/2003CA2463758A1 Salts formed of an at1-receptor antagonist and a cardiovascular agent
05/01/2003CA2463313A1 Stable composition comprising particles in a frozen aqueous matrix
05/01/2003CA2463309A1 Sterile, breathable patch for treating wound pain
05/01/2003CA2463282A1 Therapeutical agent for pruritus
05/01/2003CA2461555A1 System for administering a drug delivery device
05/01/2003CA2461181A1 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections
05/01/2003CA2458966A1 Method and system for non-vascular sensor implantation
05/01/2003CA2458958A1 Method and apparatus for dispensing inhalator medicament
05/01/2003CA2458794A1 Plasticized hydrophilic glasses for improved stabilization of biological agents
05/01/2003CA2458542A1 Enzyme inhibitors for inactivating allergens
04/2003
04/30/2003CN1414965A Sulfonamides and derivatives thereof that modulate the activeity of endothelin
04/30/2003CN1414954A Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
04/30/2003CN1414862A Antidiabetic formulation and method
04/30/2003CN1414861A Induction of mucosal immunity by vaccination via skin nute
04/30/2003CN1414856A Antiprurity agents for external use
04/30/2003CN1414855A Remedies for external use for allergic skin diseases
04/30/2003CN1414853A Oral mucosal dosage forms of apomorphine
04/30/2003CN1414852A Novel composition and use thereof
04/30/2003CN1414851A Method and formulation for treating resistance to antihypertensives and related conditions
04/30/2003CN1414847A Sustained-releasing antihelmintic compositions comprising praziquantel
04/30/2003CN1414834A Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein
04/30/2003CN1413724A Brain active effect matter for prevention and curing encephalopathy and developing intelligence and its preparation method
04/30/2003CN1413712A Relieving distension and fullness and regulating stomach capsule
04/30/2003CN1413711A Preparation technology of
04/30/2003CN1413707A Xinmai dripping pill
04/30/2003CN1413706A Elmination of toxicant and fat-lowering capsule and its preparation technology
04/30/2003CN1413696A Suppository for treating gynecopathy and its preparation technology
04/30/2003CN1413695A Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy
04/30/2003CN1413687A Medicinal cleaning solution for gynecopathy
04/30/2003CN1413678A Method for preparing refined liquid from Chinese medicinal crop
04/30/2003CN1413677A Method for preparing colored Chinese drugs extraction liquid for injection
04/30/2003CN1413676A Large-capacity compound red sage root injection and its preparation method
04/30/2003CN1413675A Hollow multifunction incense and its preparation method and using method
04/30/2003CN1413665A Momordica charantia powder lozenge and its preparation technology
04/30/2003CN1413654A Chinese medicine pill for treating cough
04/30/2003CN1413645A Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof
04/30/2003CN1413635A Quick-acting rheumatic arthritis adhesive plaster and its preparation technology
04/30/2003CN1413634A Hyperosteogeny adhesive plaster and its preparation technology
04/30/2003CN1413592A Ointment for curing multiple dermatosis
04/30/2003CN1413591A Oxygen-riched transfusion
04/30/2003CN1413583A Low dose diclofenac sodium lozenge and its preparation method
04/30/2003CN1413582A Dimethyldiguanide hydrochloride enteric solubility tablet and its preparation method
04/30/2003CN1413579A Brain health-care food and its manufacturing technology
04/30/2003CN1413578A Preparation method of sheep embryo nutrient freeze-drying powder
04/30/2003CN1413577A Thermosensitive long circulation liposome preparation
04/30/2003CN1413576A Solid-state liposome containing calcareous and its preparation method
04/30/2003CN1413575A Liposome capable of coating high content hydrophobe material
04/30/2003CN1107069C Derivatives of camptothecin for use in treating cancer and its use
04/30/2003CN1106859C Improvement in or relating to contrast agent
04/30/2003CN1106856C Medicine for treating hepatosis and its preparation method
04/30/2003CN1106854C Ointment for treating burn and scald and its preparation process
04/30/2003CN1106845C Process for preparing solid-state-microspherical vascular cuppository of sodium alginate
04/30/2003CN1106842C Usage of glutathione accelerator in preparating medicine for treating macular degeneration
04/30/2003CN1106839C Controlled release of steroids from sugar
04/30/2003CN1106838C Production process of bio-active forest frog's oviduct soft capsule
04/30/2003CN1106837C Alkalinizing potassium salt controlled release preparation
04/30/2003CN1106836C Sustained release and implantation type fluorouracil medicine and method for preparing same
04/30/2003CN1106835C Chinese medicine film and its preparation method
04/30/2003CN1106830C 稳定的油包水乳状液体系 Stable oil-in-water emulsion system
04/29/2003US6555675 Dinucleoside polyphosphates which facilitate secretory mechanisms, i.e. increasing the hydration of mucus secretions, stimulating the production of mucins and increasing ciliary beat frequency to facilitate clearance
04/29/2003US6555651 Ligand binding site of rage and uses thereof
04/29/2003US6555582 Eye treatments using synthetic thyroid hormone compositions
04/29/2003US6555581 Levothyroxine compositions and methods
04/29/2003US6555566 Methods and materials for treating and preventing inflammation of mucosal tissue
04/29/2003US6555558 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
04/29/2003US6555551 E.g. enalapril maleate, by mixing an Angiotensin Converting Enzyme (ACE) inhibitor with an alcohol, adding an aqueous solution of a metal compound, mixing to clarity, blending an excipient to form granulate, drying, adding lubricant
04/29/2003US6555546 Use of 5HT3 antagonists for promoting intestinal lavage
04/29/2003US6555544 9-hydroxyrisperidone palmitate ester having a surfactant adsorbed to the surface thereof; for administration via intramuscular or subcutaneous injection; treating psychological and neurodegenerative disorders
04/29/2003US6555532 Using estrogen receptor antagonists such as tamoxifen
04/29/2003US6555531 Weight promoting composition, method, and product
04/29/2003US6555526 Trehalos; Sjogren syndrome.